These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effectiveness and adverse events of tolvaptan in octogenarians with heart failure. Interim analyses of Samsca Post-Marketing Surveillance In Heart faiLurE (SMILE study). Kinugawa K; Inomata T; Sato N; Yasuda M; Shimakawa T; Bando K; Mizuguchi K Int Heart J; 2015; 56(2):137-43. PubMed ID: 25740389 [TBL] [Abstract][Full Text] [Related]
24. Tolvaptan for the treatment of hyponatremia and congestive heart failure. Ferrer E Drugs Today (Barc); 2010 Mar; 46(3):163-71. PubMed ID: 20467590 [TBL] [Abstract][Full Text] [Related]
25. Real-life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion. Tzoulis P; Waung JA; Bagkeris E; Carr H; Khoo B; Cohen M; Bouloux PM Clin Endocrinol (Oxf); 2016 Apr; 84(4):620-6. PubMed ID: 26385871 [TBL] [Abstract][Full Text] [Related]
26. [From hyponatremia to tolvaptan]. Cernaro V; Santoro D; Lacquaniti A; Montalto G; Buemi M G Ital Nefrol; 2014; 31(1):. PubMed ID: 24671837 [TBL] [Abstract][Full Text] [Related]
27. [The use of tolvaptan in a case of severe hyponatriemia in SIADH during meningitis]. Rollino C; Balbiano R; Caramello P; Roccatello D G Ital Nefrol; 2013; 30(6):. PubMed ID: 24402662 [TBL] [Abstract][Full Text] [Related]
28. Clinical review: the use of vaptans in clinical endocrinology. Peri A J Clin Endocrinol Metab; 2013 Apr; 98(4):1321-32. PubMed ID: 23401044 [TBL] [Abstract][Full Text] [Related]
29. Tolvaptan for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion. Gargani L; Schmidt PH; Gheorghiade M Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1505-13. PubMed ID: 22103869 [TBL] [Abstract][Full Text] [Related]
30. [Use of "Vaptans" in treatment of hyponatremia]. Tanındı A; Töre HF Turk Kardiyol Dern Ars; 2015 Apr; 43(3):292-301. PubMed ID: 25906004 [TBL] [Abstract][Full Text] [Related]
31. In-patient Tolvaptan use in SIADH: care audit, therapy observation and outcome analysis. Humayun MA; Cranston IC BMC Endocr Disord; 2017 Nov; 17(1):69. PubMed ID: 29110656 [TBL] [Abstract][Full Text] [Related]
32. [A case of venlafaxine-induced syndrome of inappropriate ADH secretion (SIADH) - treatment with tolvaptan]. Meyer I; Frank D; Janssens U Dtsch Med Wochenschr; 2012 May; 137(21):1096-9. PubMed ID: 22588654 [TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden. Jamookeeah C; Robinson P; O'Reilly K; Lundberg J; Gisby M; Ländin M; Skov J; Trueman D BMC Endocr Disord; 2016 May; 16(1):22. PubMed ID: 27184496 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of long-term tolvaptan treatment in a patient with SCLC and SIADH. Bordi P; Tiseo M; Buti S; Regolisti G; Ardizzoni A Tumori; 2015 Apr; 101(2):e51-3. PubMed ID: 25702667 [TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of tolvaptan for euvolemic or hypervolemic hyponatremia. Lee MY; Kang HJ; Park SY; Kim HL; Han E; Lee EK Clin Ther; 2014 Sep; 36(9):1183-94. PubMed ID: 25151571 [TBL] [Abstract][Full Text] [Related]
38. A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan. Petereit C; Zaba O; Teber I; Lüders H; Grohé C BMC Pulm Med; 2013 Aug; 13():55. PubMed ID: 23987478 [TBL] [Abstract][Full Text] [Related]
39. Potential roles of vaptans in heart failure: experience from clinical trials and considerations for optimizing therapy in target patients. Lin TE; Adams KF; Patterson JH Heart Fail Clin; 2014 Oct; 10(4):607-20. PubMed ID: 25217436 [TBL] [Abstract][Full Text] [Related]
40. Utility of Tolvaptan in the Perioperative Management of Severe Hyponatremia During Liver Transplantation: A Case Report. Parekh A; Rajaram P; Patel G; Subramanian RM Transplant Proc; 2017 Dec; 49(10):2399-2401. PubMed ID: 29198689 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]